DOE Isotope Program Highlights
A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
New production methods for Ce-134 advance technologies for imaging human disease and guiding treatment.
Julie Ezold, section head at ORNL, has been elected to a three-year term on the American Nuclear Society’s Board of Directors.
A new supply of a critical radioisotope advances personalized medicine.
New system makes it easier to produce isotopes for radiopharmaceutical therapy.
Number 99 does not occur naturally and is difficult to make and store, challenging researchers who want to study it.
World Cancer Day is 2/4, a time to reckon with the disease that currently impacts more than a 1M Americans per year.
When Sandra Davern looks to the future, she sees isotopes sent into the body with a specific target: cancer cells.
The ECA project enabled me to get started with solid targets for the accelerator production of radioisotopes.
Team brings a new tool for alpha therapy by developing a paired isotope option for PET scans.